February 24, 2022
Bionomics’ Half-Year Report
ADELAIDE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX: BNO, Nasdaq: BNOX), today announced its half-year report for…
Pharmaceuticals, Biotechnology and Life Sciences
ADELAIDE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX: BNO, Nasdaq: BNOX), today announced its half-year report for…
Dante Labs meets with Abu Dhabi Executive Office Dante Labs CEO Andrea Riposati and Carlo Logli meet with Dr. Fatima…
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a…
Affirms the advancements of innovative biosimulation technology and its growing impact in R&DPRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) —…
Analysis shows combinatorial approach is more effective than single-gene testing at predicting sertraline metabolism in patients with major depressive disorderSALT LAKE…
Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue of $2.8 Million, an 18%…
Achieved Oxbryta® (voxelotor) net revenues of $56.1 million in the fourth quarter and $194.7 million for full year 2021, a…
— Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of 2022 — — Proof-of-Concept Study…
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) — Cytek® Biosciences, Inc. (“Cytek…
AlloCAR T™ Studies Resumed and Currently Enrolling Patients Following Removal of Clinical Hold in January 2022Phase 1 Data from the…